Sequoia Capital China launches health, biotech-focused fund: Report

Neil Shen, managing partner of Sequoia Capital China. Photographer: Jason Alden/Bloomberg

Sequoia Capital China, widely viewed as a bellwether for Chinese tech investments, has reportedly launched a new fund that focuses on investing in publicly listed health and biotech companies.

According to The Information, Sequoia China Healthcare Partners, the new Hong Kong-based fund, will focus mainly on stocks of Chinese biotech and healthcare companies that are listed outside mainland China.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter